Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

[Deciding on treatment in Multiple Sclerosis]

[Deciding on treatment in Multiple Sclerosis] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • [Deciding on treatment in Multiple Sclerosis] Abstract Text:

    v m riveraV M Rivera,

    The modern history of the treatment of multiple sclerosis is reflected during the last years with the advent of controlled clinical trials design to produce measurable outcomes utilizing MRI techniques and statistical analysis. Addressing in this form the use of disease modifying medications: immunomodulation with interferons and glatiramer acetate in the relapsing/remitting type, and combination therapies or immunosuppression in the progressive forms, these studies based on evidence provide to the clinician direction in the process to decide the most appropriate treatment for the individual patient.

    [Deciding on treatment in Multiple Sclerosis] Publishing Authors By Initials

    vm riveraVM Rivera,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE: 2003 Jan 1-15

    [Deciding on treatment in Multiple Sclerosis] Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Revista de neurologia

    VOLUME: 36

    Page Numbers: 80-5

    Journal Abbreviation:

    ISSN: 0210-0010

    DAY: 10

    MONTH: 02

    YEAR: 2003

    [Deciding on treatment in Multiple Sclerosis] Information

    Number of References:

    LANGUAGE: spa

    NlmUniqueID: 7706841

    [Deciding on treatment in Multiple Sclerosis] Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: [Deciding on treatment in Multiple Sclerosis] Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for [Deciding on treatment in Multiple Sclerosis]

    AFFILIATION:

    Country: Spain

    Spain Research PublicationSpain Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Rev Neurol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Deciding on treatment in Multiple Sclerosis Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News